Skip to main content
Caplight Logo









Hongtai Aplus

Hongtai Aplus

Overview

Hongtai Aplus is an investment firm founded in 2014 that focuses on venture capital and fund of fund investments across China, with a focus on information technology, advanced manufacturing, pharmacy & medical care, consumption & education, and new materials.

Year Founded

2014

Portfolio Companies

5

Investments

Hongtai Aplus investments
CompanyDateStageLead
UniPat AISep 2026Early FundingCo-investor
Accro Bioscience Inc.Jan 2022Series BLead
KKVAug 2020Series ECo-investor
Luoji SiweiSep 2017Series DCo-investor
Shinehigh Innovation-Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBeijing
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?